Details of the Drug

General Information of Drug (ID: DMPD7CW)

Drug Name
LOR 253
Indication
Disease Entry ICD 11 Status REF
Metastatic cancer 2D50-2E2Z Phase 1 [1]
Cross-matching ID
TTD ID
D0MS6B

References

1 ClinicalTrials.gov (NCT01281592) A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours. U.S. National Institutes of Health.